Dr. Reddy's Laboratories Limited RDY [“Dr. Reddy's”], together
with its subsidiaries, launches the recommended public offer to acquire
all the issued and outstanding shares of OctoPlus N.V. (Euronext
Amsterdam: OCTO), a service-based specialty pharmaceutical company, at
an offer price of EUR 0.52 (cum dividend) per share. The Offer Period
commences at 14 December 2012 at 09:00 CET and ends on 8 February 2013
at 18:00 CET, unless extended.
Shareholders (including certain members of the Boards) holding in
aggregate 63.5% of the issued and outstanding ordinary shares of
OctoPlus have entered into irrevocable undertakings to tender their
shares under the Offer.
Disclaimer
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in